Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD

European Respiratory Journal

Volumn 39, Issue 5, 2012, Pages 1097-1103

  McAllister, David A ^a   Maclay, John D ^a   Mills, Nicholas L ^b   Leitch, Andrew ^c   Reid, Philip ^e   Carruthers, Ross ^f   O'Connor, Jennifer ^f   McAlpine, Lawrence ^e   Chalmers, George ^c   Newby, David E ^b   Clark, Elaine ^d   Macfarlane, Peter W ^d   MacNee, William ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e MONKLANDS HOSPITAL   (United Kingdom)

^f CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

Chest pain; Chronic obstructive pulmonary disease; ECG; Myocardial infarction; Troponin

Indexed keywords

TROPONIN;

ADULT; AGED; ARTICLE; CASE STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE EXACERBATION; ECG ABNORMALITY; FEMALE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; Q WAVE; ST SEGMENT; T WAVE; THORAX PAIN;

AGED; AGED, 80 AND OVER; CHEST PAIN; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TROPONIN;

EID: 84860483262     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00124811     Document Type: Article

References (35)

1. McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411-415. (Pubitemid 46698390)
2. Anthonisen NR, Connett JE, Enright PL, et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-339. (Pubitemid 34864422)
3. Hole DJ, Watt GCM, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-715.
4. Huiart L, Ernst P, Ranouil X, et al. Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease. Can Respir J 2006; 13: 134-138. (Pubitemid 43834004)
5. Donaldson GC, Hurst JR, Smith CJ, et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010; 137: 1091-1097.
6. Baillard C, Boussarsar M, Fosse J-P, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003; 29: 584-589. (Pubitemid 36523675)
7. Brekke PH, Omland T, Holmedal SH, et al. Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 2008; 31: 563-570.
8. Chang CL, Robinson SC, Mills GD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 2011; 66: 764-768.
9. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000; 283: 3223-3229. (Pubitemid 30422040)
10. Collinson PO, Premachandram S, Hashemi K, et al. Prospective audit of incidence of prognostically important myocardial damage in patients discharged from emergency department. BMJ 2000; 320: 1702-1705.
11. Thygesen K, Alpert JS, White HD, et al. Universal Definition of Myocardial Infarction. J Am Coll Cardiol 2007; 50: 2173-2195. (Pubitemid 350123680)
12. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002; 144: 981-986. (Pubitemid 36026910)
13. Prineas RJ. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, J Wright, 1982.
14. Macfarlane PW, Latif S. Automated serial ECG comparison based on the Minnesota code. J Electrocardiol 1996; 29: Suppl. 1, 29-34. (Pubitemid 27051630)
15. Swap CJ, Nagurney JT. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. JAMA 2005; 294: 2623-2629. (Pubitemid 41697252)
16. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204. (Pubitemid 17009877)
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA. 2001; 285: 2486-2497.
18. Brekke PH, Omland T, Holmedal SH, et al. Determinants of cardiac troponin T elevation in COPD exacerbation - a crosssectional study. BMC Pulm Med 2009; 9: 35.
19. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276-1282.
20. Sims MW, Margolis DJ, Localio AR, et al. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest 2009; 136: 412-419.
21. Abraham AS, Cole RB, Green ID, et al. Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res 1969; 24: 51-60.
22. Dransfield MT, Rowe SM, Johnson JE, et al. Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008; 63: 301-305. (Pubitemid 351497940)
23. van Gestel YR, Hoeks SE, Sin DD, et al. Impact of cardioselective β-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 2008; 178: 695-700.
24. Short PM, Lipworth SIW, Elder DHJ, et al. Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 2011; 342: d2549-d2549.
25. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874. (Pubitemid 36019640)
26. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84: 210-215. (Pubitemid 30601465)
27. Hurst JR, Perera WR, Wilkinson TMA, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 71-78. (Pubitemid 43069790)
28. Maclay JD, McAllister D, Johnston S, et al. Increased platelet activation in stable and exacerbation of COPD. Thorax 2011; 66: 769-774.
29. Sabatine MS, Morrow DA, de Lemos JA, et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009; 30: 162-169.
30. National Institute for Health and Clinical Excellence. Chest pain of recent onset. http://guidance.nice.org.uk/CG95 Date last accessed: April 13, 2010. Date last updated: January 19, 2012.
31. Brekke PH, Omland T, Smith P, et al. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 2008; 102: 1243-1247.
32. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519. (Pubitemid 36378490)
33. Buckingham R, Lowe D, Roberts M, et al. National COPD Audit 2008. London, Royal College of Physicians, 2008.
34. Mahajan N, Mehta Y, Rose M, et al. Elevated troponin level is not synonymous with myocardial infarction. Int J Cardiol 2006; 111: 442-449. (Pubitemid 44205299)
35. Rutschmann OT, Cornuz J, Poletti P-A, et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax 2007; 62: 121-125.